Finance

Beta
Lists
LOVE:TSE
Cannara Biotech Inc
CA$1.61
-1.83%
(-0.030) 1D
Jun 4, 12:14:39 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for LOVE...
Open
CA$1.66
High
CA$1.66
Low
CA$1.58
Mkt. cap
159.04M
Avg. vol.
43.45K
Volume
35.25K
P/E ratio
14.92
52-wk high
CA$2.07
52-wk low
CA$1.08
EPS
CA$0.11
Beta
0.37
Shares outstanding
98.78M
No. of employees
452
Open
CA$1.66
High
CA$1.66
Low
CA$1.58
Mkt. cap
159.04M
Avg. vol.
43.45K
Volume
35.25K
P/E ratio
14.92
52-wk high
CA$2.07
52-wk low
CA$1.08
EPS
CA$0.11
Beta
0.37
Shares outstanding
98.78M
No. of employees
452
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to LOVE in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for LOVE in the last 3 months.
Highest
Current CA$1.61
CA$3.25 (+101.86%)
Average
CA$3.09 (+91.64%)
Lowest
CA$3.00 (+86.34%)
News stories
From sources across the web
About Cannara Biotech Inc
CEO-
Employees452
Founded2017
Headquarters-
SectorPersonal care products
Websitecannara.ca
Last report
Apr 14, 2026
Fiscal period
Q2 2026
EPS / Est. (CAD)
CA$0.02 / CA$0.04
-53.50%miss
Revenue / Est. (CAD)
27.15M / 31.70M
-14.35%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
May 2025
Aug 2025
Nov 2025
Feb 2026
Revenue
27.27M
28.52M
30.11M
27.15M
Cost of goods sold
14.45M
16.13M
18.90M
15.53M
Cost of revenue
14.45M
16.13M
18.90M
15.53M
Research and development expenses
176.94K
191.15K
287.45K
400.70K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.46M
6.02M
6.23M
6.50M
Operating expense
6.12M
7.30M
8.51M
8.25M
Total operating expenses
20.57M
23.43M
27.41M
23.78M
Operating income
6.70M
5.09M
2.70M
3.37M
Other non operating income
-60.86K
-379.12K
-73.54K
-93.55K
EBT including unusual items
5.79M
4.54M
2.04M
2.82M
EBT excluding unusual items
5.79M
4.00M
2.04M
2.94M
Income tax expense
1.65M
1.23M
1.00M
1.16M
Effective tax rate
28.49%
27.03%
49.07%
41.04%
Other operating expenses
-
-
-
-
Net income
4.14M
3.31M
1.04M
1.66M
Net profit margin
15.19%
11.62%
3.45%
6.12%
Earnings per share
-
-
-
0.02
Interest and investment income
62.19K
89.58K
82.70K
84.27K
Interest expense
-937.60K
-805.27K
-608.11K
-465.53K
Net interest expenses
-875.41K
-715.69K
-525.41K
-381.26K
Depreciation and amortization charges
-
-
266.74K
252.99K
EBITDA
7.89M
7.26M
4.22M
4.61M
Gain or loss from assets sale
-1.51K
-422.17K
-
122.01K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more